Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A in Adults With Cerebral Palsy
NCT00432055Phase 4Completed
- Sponsor
- Sunnaas Rehabilitation Hospital
- Start
- Jan 2007
- Primary completion
- Jan 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in cerebral palsy (CP) comparing Botox with Placebo (2 arms). Primary endpoints: Ankle sagittal kinematic with corresponding knee and hip data (3D-gait analysis) at 8 weeks and Summary measure of health related quality of life (SF-36) at 16 weeks. Started Jan 2007; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on NCT00432055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00432055.